ExLibris header image
SFX Logo
Title: Dynamics of clonal evolution in myelodysplastic syndromes
Source:

Nature Genetics [1061-4036] Makishima, Hideki yr:2016


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Kohlmann, A. "Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing." Leukemia & lymphoma 55.8 (2013): 1725-1734. Link to SFX for this item
2. Tarlock, K. "Gemtuzumab ozogamicin reduces relapse risk in FLT3/ITD acute myeloid leukemia: a report from the Children's Oncology Group." Clinical cancer research 22.8 (2015): 1951-1957. Link to SFX for this item
3. Steensma, David P. "Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes." Blood 126.1 (2015): 9-16. Link to SFX for this item
4. Schinke, C. "Stem cell origin of myelodysplastic syndromes." Oncogene 33.44 (2013): 5139-50. Link to Full Text for this item Link to SFX for this item
5. Bains, A. "FLT3 and NPM1 Mutations in Myelodysplastic Syndromes Frequency and Potential Value for Predicting Progression to Acute Myeloid Leukemia." American journal of clinical pathology 135.1 (2011): 62-69. Link to SFX for this item
6. "Improving Prognostic Tools for Patients With Myelodysplastic Syndromes." Mayo Clinic Proceedings. 93.10: 1340-1342. Link to SFX for this item
7. Imrichova, D. "Selection of resistant acute myeloid leukemia SKM-1 and MOLM-13 cells by vincristine-, mitoxantrone- and lenalidomide-induced upregulation of P-glycoprotein activity and downregulation of CD33 cell surface exposure." European journal of pharmaceutical sciences 77 (2015): 29-39. Link to SFX for this item
8. Schetelig, W. "Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial." Leukemia 30.2 (2016): 261-267. Link to Full Text for this item Link to SFX for this item
9. Ninomiya, H. "Inhibition of complement-mediated haemolysis in paroxysmal nocturnal haemoglobinuria by heparin or low-molecular weight heparin." British journal of haematology 109.4 (2000): 875-81. Link to Full Text for this item Link to SFX for this item
10. Coombs, C. "Molecular therapy for acute myeloid leukaemia." Nature Reviews Clinical Oncology 13.5 (2015): 305-318. Link to SFX for this item
11. Kwok, B. "MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance." Blood 126.21 (2015): 2355-61. Link to SFX for this item
12. Ayllón, V. "The Notch ligand DLL4 specifically marks human hematoendothelial progenitors and regulates their hematopoietic fate." Leukemia 29.8 (2015): 1741-1753. Link to Full Text for this item Link to SFX for this item
13. Cortese, D. "TARGETED NEXT-GENERATION SEQUENCING FOR MUTATIONAL SCREENING IN CHRONIC LYMPHOCYTIC LEUKEMIA: A HIGH-THROUGHPUT YET TAILORED APPROACH WILL FACILITATE IMPLEMENTATION WITHIN A CLINICAL SETTING." Haematologica 2014. 313-314. Link to Full Text for this item Link to SFX for this item
14. Gamis, Alan S. "Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531." Journal of clinical oncology 32.27 (2014): 3021-32. Link to SFX for this item
15. Sekeres, Mikkael A. "Improving the diagnosis and treatment of patients with myelodysplastic syndromes through a performance improvement initiative." Leukemia research 37.4 (2013): 422-426. Link to SFX for this item
16. Bhatnagar, B. "The Use of Molecular Genetics to Refine Prognosis in Acute Myeloid Leukemia." Current Hematologic Malignancy Reports 9.2 (2014): 148-157. Link to SFX for this item
17. Rochau, U. "Medical Decision Analysis for the First-line Therapy of Chronic Myeloid Leukemia." Leukemia & lymphoma 55.8 (2013): 1758-1767. Link to SFX for this item
18. Gillis, Nancy K. "Clinical Implementation of Germline Cancer Pharmacogenetic Variants during the Next-Generation Sequencing Era." Clinical pharmacology & therapeutics 95.3 (2013): 269-280. Link to SFX for this item
19. Hou, H. "Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression." American journal of hematology 89.2 (2013): 181-186. Link to Full Text for this item Link to SFX for this item
20. Lindsley, Benjamin C. "The biology and clinical impact of genetic lesions in myeloid malignancies." Blood 122.23 (2013): 3741-8. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.